Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.

The Cochrane Database of Systematic Reviews
Emil Ørskov IpsenBianca Hemmingsen

Abstract

The term prediabetes is used to describe a population with an elevated risk of developing type 2 diabetes mellitus (T2DM). With projections of an increase in the incidence of T2DM, prevention or delay of the disease and its complications is paramount. It is currently unknown whether pioglitazone is beneficial in the treatment of people with increased risk of developing T2DM. To assess the effects of pioglitazone for prevention or delay of T2DM and its associated complications in people at risk of developing T2DM. We searched CENTRAL, MEDLINE, Chinese databases, ICTRP Search Portal and ClinicalTrials.gov. We did not apply any language restrictions. Further, we investigated the reference lists of all included studies and reviews. We tried to contact all study authors. The date of the last search of databases was November 2019 (March 2020 for Chinese databases). We included randomised controlled trials (RCTs) with a minimum duration of 24 weeks, and participants diagnosed with intermediate hyperglycaemia with no concomitant diseases, comparing pioglitazone as monotherapy or part of dual therapy with other glucose-lowering drugs, behaviour-changing interventions, placebo or no intervention. Two review authors independently screened...Continue Reading

References

May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jan 25, 2003·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Apr 21, 2005·BMC Medical Research Methodology·Stela Pudar HozoIztok Hozo
Mar 21, 2006·Metabolism: Clinical and Experimental·Cynthia ChengBonita E Falkner
Oct 21, 2006·The Cochrane Database of Systematic Reviews·B RichterS H Ebrahim
Dec 1, 2006·The New England Journal of Medicine·Renata BelfortKenneth Cusi
May 1, 2007·Journal of Hepatology·Lawrence Serfaty
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Apr 22, 2009·Journal of the Royal Statistical Society. Series A, (Statistics in Society)·Julian P T HigginsDavid J Spiegelhalter
Jun 9, 2009·Diabetes Care·UNKNOWN International Expert Committee
Jul 31, 2009·BMC Endocrine Disorders·Ralph A DefronzoDevjit Tripathy
Sep 3, 2009·JAMA : the Journal of the American Medical Association·Sylvain MathieuPhilippe Ravaud
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Feb 17, 2010·BMJ : British Medical Journal·Jamie J KirkhamPaula R Williamson
Sep 8, 2010·BMJ : British Medical Journal·Deborah Cohen
Nov 3, 2010·Journal of Evaluation in Clinical Practice·Bowers MeganMark Weatherall
Mar 2, 2011·Annals of Internal Medicine·Elizabeth SelvinFrederick L Brancati
Mar 8, 2011·Annals of the Rheumatic Diseases·Maya H BuchJosef S Smolen
Mar 25, 2011·The New England Journal of Medicine·Ralph A DeFronzoUNKNOWN ACT NOW Study
Jun 1, 2011·Epidemiologic Reviews·Anthony J Viera
Sep 29, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·H-B YangX-F Wang
Jan 5, 2012·BMJ : British Medical Journal·Beth HartLisa Bero
Aug 10, 2012·The New England Journal of Medicine·Silvio E Inzucchi
Nov 24, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Aramesh SaremiPeter D Reaven
Jan 30, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Asbjørn HróbjartssonStig Brorson
Jul 10, 2013·Diabetes
Jul 10, 2013·Diabetes

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Hiroyoshi Yokoi
Nihon rinsho. Japanese journal of clinical medicine
Masashi KobayashiKazuyuki Hiratani
Nihon rinsho. Japanese journal of clinical medicine
Yoshimasa Aso
JPMA. the Journal of the Pakistan Medical Association
Sanjay Kalra, Yashdeep Gupta
Annals of Translational Medicine
Ralph DeFronzoJassim Al-Suwaidi
© 2021 Meta ULC. All rights reserved